These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

690 related articles for article (PubMed ID: 10088777)

  • 1. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
    Lohmander LS; Ionescu M; Jugessur H; Poole AR
    Arthritis Rheum; 1999 Mar; 42(3):534-44. PubMed ID: 10088777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procollagen II C-propeptide in joint fluid: changes in concentration with age, time after knee injury, and osteoarthritis.
    Lohmander LS; Yoshihara Y; Roos H; Kobayashi T; Yamada H; Shinmei M
    J Rheumatol; 1996 Oct; 23(10):1765-9. PubMed ID: 8895155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis.
    Squires GR; Okouneff S; Ionescu M; Poole AR
    Arthritis Rheum; 2003 May; 48(5):1261-70. PubMed ID: 12746899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover: analyses of synovial fluid from patients with osteoarthritis.
    Ishiguro N; Ito T; Ito H; Iwata H; Jugessur H; Ionescu M; Poole AR
    Arthritis Rheum; 1999 Jan; 42(1):129-36. PubMed ID: 9920023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
    Lark MW; Bayne EK; Flanagan J; Harper CF; Hoerrner LA; Hutchinson NI; Singer II; Donatelli SA; Weidner JR; Williams HR; Mumford RA; Lohmander LS
    J Clin Invest; 1997 Jul; 100(1):93-106. PubMed ID: 9202061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential levels of synovial fluid aggrecan aggregate components in experimental osteoarthritis and joint disuse.
    Ratcliffe A; Beauvais PJ; Saed-Nejad F
    J Orthop Res; 1994 Jul; 12(4):464-73. PubMed ID: 7520485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The release of aggrecan fragments into synovial fluid after joint injury and in osteoarthritis.
    Lohmander LS
    J Rheumatol Suppl; 1995 Feb; 43():75-7. PubMed ID: 7752145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
    Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
    Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential matrix degradation and turnover in early cartilage lesions of human knee and ankle joints.
    Aurich M; Squires GR; Reiner A; Mollenhauer JA; Kuettner KE; Poole AR; Cole AA
    Arthritis Rheum; 2005 Jan; 52(1):112-9. PubMed ID: 15641059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis.
    Lohmander LS; Saxne T; Heinegård DK
    Ann Rheum Dis; 1994 Jan; 53(1):8-13. PubMed ID: 8311563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal patterns of stromelysin-1, tissue inhibitor, and proteoglycan fragments in human knee joint fluid after injury to the cruciate ligament or meniscus.
    Lohmander LS; Roos H; Dahlberg L; Hoerrner LA; Lark MW
    J Orthop Res; 1994 Jan; 12(1):21-8. PubMed ID: 8113939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage.
    Glant TT; Cs-Szabó G; Nagase H; Jacobs JJ; Mikecz K
    Arthritis Rheum; 1998 Jun; 41(6):1007-18. PubMed ID: 9627010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated intraarticular injections of triamcinolone acetonide alter cartilage matrix metabolism measured by biomarkers in synovial fluid.
    Céleste C; Ionescu M; Robin Poole A; Laverty S
    J Orthop Res; 2005 May; 23(3):602-10. PubMed ID: 15885481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of synovial fluid markers of cartilage synthesis and turnover to study effects of repeated intra-articular administration of methylprednisolone acetate on articular cartilage in vivo.
    Robion FC; Doizé B; Bouré L; Marcoux M; Ionescu M; Reiner A; Poole AR; Laverty S
    J Orthop Res; 2001 Mar; 19(2):250-8. PubMed ID: 11347698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tenascin-C levels in synovial fluid are elevated after injury to the human and canine joint and correlate with markers of inflammation and matrix degradation.
    Chockalingam PS; Glasson SS; Lohmander LS
    Osteoarthritis Cartilage; 2013 Feb; 21(2):339-45. PubMed ID: 23142724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).
    Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR
    Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered patterns and synthesis of extracellular matrix macromolecules in early osteoarthritis.
    Lorenzo P; Bayliss MT; Heinegård D
    Matrix Biol; 2004 Oct; 23(6):381-91. PubMed ID: 15533759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in cartilage type-II procollagen and aggrecan contents in synovial fluid in equine osteochondrosis.
    Laverty S; Ionescu M; Marcoux M; Bouré L; Doizé B; Poole AR
    J Orthop Res; 2000 May; 18(3):399-405. PubMed ID: 10937626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cartilage metabolism in the injured and uninjured knee of the same patient.
    Dahlberg L; Roos H; Saxne T; Heinegård D; Lark MW; Hoerrner LA; Lohmander LS
    Ann Rheum Dis; 1994 Dec; 53(12):823-7. PubMed ID: 7864691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.